季铵化融合β-碳胺抗mrsa药物的合成及生物评价。

IF 3.4 4区医学 Q2 CHEMISTRY, MEDICINAL

ChemMedChem Pub Date : 2025-05-21 DOI:10.1002/cmdc.202500326

Adilakshmi Vutla, Deepanshi Saxena, Rahul Maitra, Sidharth Chopra, Sanjay Batra

引用次数: 0

摘要

Adilakshmi Vutla和Deepanshi Saxena对手稿的贡献相同。[c]中的地址应改为：印度科学与创新研究学院，Ghaziabad 201002。代替科学与创新研究学院，csir -人力资源开发中心（CSIR-HRDC），校园19区，Kamla Nehru Nagar, Ghaziabad 201002, Uttar Pradesh 226031对作者的过失表示遗憾。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Synthesis and Bio-evaluation of Quaternized Fused-β-carbolines as anti-MRSA agents

查看原文本刊更多论文

Synthesis and Bio-evaluation of Quaternized Fused-β-carbolines as anti-MRSA agents

Adilakshmi Vutla and Deepanshi Saxena Contributed equally to the manuscript.

The address in [c] should be read as

Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.

Instead of

Academy of Scientific and Innovative Research, CSIR-Human Resource Development Centre (CSIR-HRDC), Campus Sector 19, Kamla Nehru Nagar, Ghaziabad 201002, Uttar Pradesh 226031, India.

The inadvertent error by the authors is regretted.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.